![breast cancer and semaglutide is Associated with Improved Survival, Lower Metastatic Burden, a Dose–Survival Relationship Uncoupled from Weight-Loss Magnitude[v1] New study examines GLP-1 drugs](https://www.preprints.org/frontend/picture/ms_xml/manuscript/b7424c95405790796f3d052b9ff68951/preprints-210091-g001.png)
breast cancer and semaglutide is Associated with Improved Survival, Lower Metastatic Burden, a Dose–Survival Relationship Uncoupled from Weight-Loss Magnitude[v1] New study examines GLP-1 drugs
USD25.10
USD58.10
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
![breast cancer and semaglutide is Associated with Improved Survival, Lower Metastatic Burden, a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] New study examines GLP-1 drugs](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1201022638881394)
![breast cancer and semaglutide is Associated with Improved Survival, Lower Metastatic Burden, a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] New study examines GLP-1 drugs](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3911481544035415196)
![breast cancer and semaglutide is Associated with Improved Survival, Lower Metastatic Burden, a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] New study examines GLP-1 drugs](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3915649923006273308)
![breast cancer and semaglutide is Associated with Improved Survival, Lower Metastatic Burden, a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] New study examines GLP-1 drugs](https://npr.brightspotcdn.com/dims3/default/strip/false/crop/5400x3038+0+209/resize/1400/quality/85/format/jpeg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F32%2F86%2F765aa4704e13aac27deda3103de6%2Fgettyimages-2279484839.jpg)
